Skip to main content

Advertisement

Log in

Evaluation of aortic calcification using a three-dimensional volume-rendering method in patients with end-stage kidney disease

  • Original Article
  • Published:
Journal of Bone and Mineral Metabolism Aims and scope Submit manuscript

Abstract

Introduction

Very few studies have been performed to evaluate both the severity and site of aortic calcification (AC) in both end-stage kidney disease (ESKD) and diabetes mellitus (DM). The purpose of our study was to examine the utility of a newly developed three-dimensional (3D) visualization and quantification method compared with other methods to evaluate vascular calcification in ESKD patients with and without DM.

Materials and methods

Fifty patients with ESKD before initiating hemodialysis at our hospital were included in the present study. They were divided into the two groups, depending on the presence or absence of DM: Control group (n = 31) and DM group (n = 19). The volume and site of AC were evaluated via computed tomography (CT) scan using a 3D visualization and quantification method.

Results

Total calcification volume was significantly greater in the DM group than in the Control group. Calcification volume in the descending and abdominal aortas was greater in the DM group compared to the Control group. There were no significant differences in calcification volume in the aortic root, ascending aorta, and aortic arch. Calcification volume of the whole aorta, the descending aorta, and the abdominal aorta were each significantly correlated with age, diastolic blood pressure and pulse pressure.

Conclusion

This study using a 3D visualization and quantification method demonstrated that AC was more severe and occurred more frequently in the abdominal aorta in ESKD patients with DM compared to those without DM. This method would enable us to precisely evaluate the volume and distribution of AC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Saran R, Robinson B, Abbott KC, Bragg-Gresham J, Chen X, Gipson D, Gu H, Hirth RA, Hutton D, Jin Y, Kapke A (2019) US renal data system 2019 annual data report. Am J Kidney Dis 75:A6

    Article  Google Scholar 

  2. Ishigami J, Cowan LT, Demmer RT et al (2020) Incident hospitalization with major cardiovascular diseases and subsequent risk of ESKD: implications for cardiorenal syndrome. J Am Soc Nephrol 31:405–414

    Article  CAS  Google Scholar 

  3. Fujii H, Joki N (2017) Mineral metabolism and cardiovascular disease in CKD. Clin Exp Nephrol 21:S53

    Article  Google Scholar 

  4. Goto S, Kitamura K, Kono K et al (2013) Association between AST-120 and abdominal aortic calcification in predialysis patients with chronic kidney disease. Clin Exp Nephrol 17:365–371

    Article  CAS  Google Scholar 

  5. Ishimura E, Okuno S, Kitatani K et al (2002) Different risk factors for peripheral vascular calcification between diabetic and non-diabetic haemodialysis patients–importance of glycaemic control. Diabetologia 45:1446–1448

    Article  CAS  Google Scholar 

  6. Detrano R et al (2008) Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 358:1336–1345

    Article  CAS  Google Scholar 

  7. Rennenberg RJ, Kessels AG, Schurgers LJ et al (2009) Vascular calcifications as a marker of increased cardiovascular risk: a meta-analysis. Vasc Health Risk Manag 5:185–197

    Article  CAS  Google Scholar 

  8. London GM, Guérin AP, Marchais SJ et al (2003) Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18:1731–1740

    Article  Google Scholar 

  9. Moe S, Drüeke T, Cunningham J et al (2006) Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int 69:1945

    Article  CAS  Google Scholar 

  10. Yahagi K et al (2017) Pathology of human coronary and carotid artery atherosclerosis and vascular calcification in diabetes mellitus. Arterioscler Thromb Vasc Biol 37:191–204

    Article  CAS  Google Scholar 

  11. Sarwar N, Gao P, Seshasai SR et al (2010) Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 375:2215–2222

    Article  CAS  Google Scholar 

  12. Fukagawa M, Yokoyama K, Koiwa F et al (2013) CKD-MBD Guideline Working Group; Japanese Society for Dialysis Therapy. Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder. Ther Apher Dial 17:247–288

    Article  Google Scholar 

  13. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO (2017) Clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int 7:1–59

    Article  Google Scholar 

  14. Fujii H, Kono K, Nakai K, Goto S, Nishii T, Kono A, Nishi S (2018) Effects of lanthanum carbonate on coronary artery calcification and cardiac abnormalities during initiating hemodialysis. Calcif Tissue Int 102:310–3208

    Article  CAS  Google Scholar 

  15. Mori S, Takaya T, Kinugasa M et al (2015) Three-dimensional quantification and visualization of aortic calcification by multidetector-row computed tomography: a simple approach using a volume-rendering method. Atherosclerosis 239:622–628

    Article  CAS  Google Scholar 

  16. Hanada S, Ando R, Naito S, Kobayashi N, Wakabayashi M, Hata T, Sasaki S (2010) Assessment and significance of abdominal aortic calcification in chronic kidney disease. Nephrol Dial Transplant 25:1888–1895

    Article  Google Scholar 

  17. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R (1990) Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15:827–832

    Article  CAS  Google Scholar 

  18. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl 113:S1-130

    Google Scholar 

  19. Goldsmith DA, Covic A, Fouque D et al (2010) Endorsement of the kidney disease improving global outcomes (KDIGO) chronic kidney disease-mineral and bone disorder (CKD-MBD) guidelines: a european renal best practice (ERBP) commentary statement. Nephrol Dial Transplant 25:3823–3831

    Article  Google Scholar 

  20. Agatston AS, Janowitz WR, Hildner FJ et al (1990) Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15:827–832

    Article  CAS  Google Scholar 

  21. Karohl C, Gascón LD, Raggi P (2011) Noninvasive imaging for assessment of calcification in chronic kidney disease. Nat Rev Nephrol 7:567–577

    Article  CAS  Google Scholar 

  22. Adragao T, Pires A, Lucas C, Birne R, Magalhaes L, Goncalves M, Negrao AP (2004) A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients. Nephrol Dial Transplant 19:1480–1488

    Article  Google Scholar 

  23. Hanada S, Ando S, Naito S et al (2010) Assessment and significance of abdominal aortic calcification in chronic kidney disease. Nephrol Dial Transplant 25:1888–1895

    Article  Google Scholar 

  24. Vervloet M, Cozzolino M (2017) Vascular calcification in chronic kidney disease: different bricks in the wall? Kidney Int 91:808–817

    Article  Google Scholar 

  25. Criqui MH, Denenberg JO, Ix JH et al (2014) Calcium density of coronary artery plaque and risk of incident cardiovascular events. JAMA 311:271–278

    Article  CAS  Google Scholar 

  26. Kono K, Fujii H, Nakai K et al (2012) Compositional plaque pattern of coronary culprit lesion and clinical characteristics in chronic kidney disease patients: a virtual histology-intravascular ultrasound (VH-IVUS) analysis. Kidney Int 82:344–351

    Article  CAS  Google Scholar 

  27. Manzoor S, Ahmed S, Ali A et al (2018) Progression of medial arterial calcification in CKD. Kidney Int Rep 3:1328–1335

    Article  Google Scholar 

  28. Suzuki C, Nakamura S, Ishibashi-Ueda H, Yoshihara F, Kawano Y (2011) Evidence for severe atherosclerotic changes in chronic hemodialysis patients: comparative autopsy study against cardiovascular disease patients without chronic kidney disease. Ther Apher Dial 15:51–57

    Article  Google Scholar 

  29. Itani Y, Watanabe S, Masuda Y (2004) Aortic calcification detected in a mass chest screening program using a mobile helical computed tomography unit. Circ J 68:538–541

    Article  Google Scholar 

  30. Allison MA, Criqui MH, Wright CM (2004) Patterns and risk factors for systemic calcified atherosclerosis. Arterioscler Thromb Vasc Biol 24:331–336

    Article  CAS  Google Scholar 

  31. Fujii H, Nakai K, Goto S, Nishi S (2015) Clinical characteristics of the very elderly patients at hemodialysis initiation. Intern Med 54:579–583

    Article  CAS  Google Scholar 

Download references

Funding

This study was partly supported by grants from Bayer Yakuhin Co. and Kidney Foundation (Japan, JKFB11-30). The funders had no roles in study design, data collection, data analysis, data interpretation, or preparation of this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hideki Fujii.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fujii, H., Kono, K., Watanabe, K. et al. Evaluation of aortic calcification using a three-dimensional volume-rendering method in patients with end-stage kidney disease. J Bone Miner Metab 39, 439–445 (2021). https://doi.org/10.1007/s00774-020-01172-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00774-020-01172-4

Keywords

Navigation